Pacific Smiles Group Ltd (ASX: PSQ) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Pacific Smiles Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $302.41 million
P/E Ratio 45.67
Dividend Yield 2.30%
Shares Outstanding 159.58 million
Earnings per share 0.042
Dividend per share 0.04
Year To Date Return 31.58%
Earnings Yield 2.19%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Pacific Smiles Group Ltd (ASX: PSQ)
    Latest News

    a woman holds her hands up in delight as she sits in front of her lap
    Share Gainers

    Why Boss Energy, Pacific Smiles, Perpetual, and ResMed shares are racing higher

    These ASX shares are starting the week strongly. But why?

    Read more »

    A young woman smiling and looking happy, indicating a positive share price movement on the ASX market
    Mergers & Acquisitions

    Why this ASX All Ords stock is sparkling 15% brighter today

    Shareholders of this stock are smiling widely today.

    Read more »

    Surge in ASX share price represented by happy woman pointing to her big smile
    Mergers & Acquisitions

    Guess which ASX All Ords share just rocketed 18% on takeover news

    The ASX All Ords share is lifting off on Monday amid takeover news.

    Read more »

    Health workers shake hands and congratulate each other on good news.
    Earnings Results

    4 ASX healthcare shares charging higher on positive earnings updates

    These ASX healthcare shares are recording strong share price gains today.

    Read more »

    Five people in an office high five each other.
    Share Market News

    5 ASX All Ords shares just upgraded by top brokers

    Leading brokers have just given their tick of approval to these five ASX All Ords shares.

    Read more »

    A man wearing a white coat holds his hands up and mouth open with joy.
    Healthcare Shares

    'Highly sought-after': 3 ASX healthcare shares ready to roar again

    Before the COVID-19 pandemic, this sector was going absolutely gangbusters. One expert reckons it's ready to rock again.

    Read more »

    three children wearing superhero costumes, complete with masks, pose with hands on hips wearing capes and sneakers on a running track.
    Broker Notes

    'Revenues up 59%': 3 small-cap ASX shares rocketing right now (and set for more gains)

    QVG analysts are loving this trio of companies going gangbusters in 2023.

    Read more »

    A woman looks excited as she fans out a wad of Aussie $100 notes.
    Dividend Investing

    4 ASX All Ordinaries shares trading ex-dividend on Wednesday

    These four businesses are about to allocate their payments to shareholders.

    Read more »

    Frequently Asked Questions

    Yes, Pacific Smiles Group has historically paid one or two fully franked shareholder dividends a year.

    Pacific Smiles Group Limited list on the ASX on 21 November 2014.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    21 Mar 2024 $0.0210 100.00% Interim 05 Apr 2024
    21 Sep 2023 $0.0227 100.00% Final 09 Oct 2023
    22 Mar 2023 $0.0035 100.00% Interim 06 Apr 2023
    24 Mar 2021 $0.0240 100.00% Interim 09 Apr 2021
    18 Mar 2020 $0.0240 100.00% Interim 01 May 2020
    18 Sep 2019 $0.0350 100.00% Final 04 Oct 2019
    18 Mar 2019 $0.0230 100.00% Interim 05 Apr 2019
    19 Sep 2018 $0.0380 100.00% Final 05 Oct 2018
    16 Mar 2018 $0.0230 100.00% Interim 04 Apr 2018
    14 Sep 2017 $0.0000 100.00% Final 03 Oct 2017
    15 Sep 2016 $0.0350 100.00% Final 04 Oct 2016
    15 Mar 2016 $0.0200 100.00% Interim 01 Apr 2016

    PSQ ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Pacific Smiles Group Ltd

    Pacific Smiles Group Limited (ASX: PSQ) operates more than 120 dental centres nationally while more than 800 dentists operate their practices under the company's framework. In those practices, Pacific Smiles provides facilities, dental equipment, and support staff, while dental practitioners maintain clinical autonomy. The group owns and operates Pacific Smiles Dental and nib Dental Care centres across Australia's east coast and also manages operations of HBF Dental Centres in Western Australia. 

     

    PSQ Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    22 May 2024 $1.90 $0.00 0.00% 54,931 $1.92 $1.92 $1.90
    21 May 2024 $1.90 $-0.01 -0.52% 456,069 $1.90 $1.91 $1.90
    20 May 2024 $1.91 $0.01 0.53% 100,997 $1.91 $1.91 $1.91
    17 May 2024 $1.90 $-0.01 -0.52% 65,595 $1.91 $1.91 $1.90
    16 May 2024 $1.91 $0.00 0.00% 136,063 $1.90 $1.91 $1.90
    15 May 2024 $1.91 $0.01 0.53% 87,719 $1.90 $1.91 $1.90
    14 May 2024 $1.90 $0.00 0.00% 13,397 $1.90 $1.90 $1.90
    13 May 2024 $1.90 $0.00 0.00% 243,416 $1.91 $1.91 $1.90
    10 May 2024 $1.90 $0.00 0.00% 787,012 $1.90 $1.90 $1.90
    09 May 2024 $1.90 $-0.01 -0.52% 522,028 $1.90 $1.90 $1.90
    08 May 2024 $1.91 $0.01 0.53% 261,996 $1.91 $1.91 $1.90
    07 May 2024 $1.90 $0.01 0.53% 98,340 $1.90 $1.90 $1.90
    06 May 2024 $1.89 $0.00 0.00% 56,892 $1.90 $1.91 $1.89
    03 May 2024 $1.89 $-0.01 -0.53% 130,877 $1.90 $1.90 $1.88
    02 May 2024 $1.90 $0.02 1.07% 1,052,304 $1.88 $1.90 $1.87
    01 May 2024 $1.88 $0.00 0.00% 103,936 $1.87 $1.89 $1.87
    30 Apr 2024 $1.87 $0.00 0.00% 2,615,042 $1.88 $1.89 $1.87
    29 Apr 2024 $1.87 $0.24 14.72% 423,612 $1.85 $1.90 $1.85
    26 Apr 2024 $1.63 $0.00 0.00% 168,389 $1.63 $1.65 $1.63
    24 Apr 2024 $1.63 $-0.01 -0.61% 201,290 $1.64 $1.65 $1.63
    23 Apr 2024 $1.64 $-0.03 -1.80% 22,769 $1.64 $1.65 $1.64

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    27 Nov 2023 Jodie Leonard Buy 22,500 $20,250
    On-market trade.
    24 Nov 2023 Giselle Collins Buy 10,000 $9,450
    On-market trade.
    24 Nov 2023 Zita Peach Buy 55,000 $51,095
    On-market trade.
    24 Nov 2023 Steven Rubic Buy 100,000 $92,000
    On-market trade.
    29 Aug 2023 Zita Peach Buy 29,913 $42,655
    On-market trade. 50,087 as prior holding, as per announcement on 31-08-2023
    25 Aug 2023 Jodie Leonard Buy 16,000 $20,800
    On-market trade.
    23 Aug 2023 Philip McKenzie Expiry 850,000 $1,075,250
    As advised by the company. 2,650,000 Performance Rights, Lapse of Performance Rights, As per announcement on 29-08-2023

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Zita Peach Non-Executive DirectorNon-Executive Chairman Aug 2017
    Ms Peach has more than 25 years of commercial experience in the pharmaceutical, biotechnology, medical devices and health services industries. She has sales and marketing experience across multiple sectors in healthcare, locally and internationally, as well as international expansions and conducting business transactions. Zita was Executive Vice President for South Asia Pacific, Managing Director for Australia and New Zealand and Chair of the Boards for Malaysia, Australia and New Zealand.
    Mr Mark Alan Bloom Non-Executive Director Oct 2019
    Mr Bloom's executive career as a Finance Executive has spanned 36 years as Chief Financial Officer and an Executive Director at 3 listed entities in Real Estate. He has experience in running global and local Finance and IT teams encompassing Treasury, Tax, Operations Finance, Compliance, Risk Management, Financial Reporting, Legal and Information Technology.
    Ms Jodie Lee Leonard Non-Executive Director May 2023
    Mr Leonard has over 30 years of experience in various marketing roles at firms including GE Capital (as Chief Marketing Officer), Nine Network Australia, Telstra, British Airways, Colgate Palmolive, and Unilever.
    Ms Giselle Marie Collins Non-Executive Director Nov 2023
    Ms Collins is a Director with executive experience in property, tourism and financial services, as well as having worked in professional services with KPMG in Sydney, London and Switzerland. Giselle is currently Chair of Hotel Property Investments (ASX:HPI) as well as a Non-Executive Director of Generation Development Group (ASX:GDG) and Cooper Energy (ASX:COE). Giselle is also Chair of the Responsible Entity for AMPs registered managed investment schemes and a Trustee of the Royal Botanic Gardens and Domain Trust until December this year when her term ends. Giselles past board experience includes being the Chair of Aon Superannuation, Chair of the Travelodge Hotel Group and Chair of the Heart Research Institute. She has also served on the Boards of BIG4 Holiday Parks, Vinomofo, ASX listed Peak Rare Earths and the Royal Australian Institute of Architects.
    Dr Scott Kalniz Non-Executive Director Jan 2021
    Dr. Kalniz has over 20 years of dental industry experience in the United States. Dr. Kalniz then partnered with a private equity firm, as CEO and Chief Dental Officer, to create a new Chicago headquartered Dental Services Organisation (DSO), Elite Dental Partners.
    Mr Steven Rubic Non-Executive Director May 2023
    Mr Rubic has over 30 years of experience in senior leadership roles, most recently as CEO of private healthcare provider Healthscope, and previously CEO of I-MED Radiology Network and St Vincents & Mater Health. He is currently a Non-Executive Director of Healthscope and the Mercy Partners, with previous board experience including Monte Sant Angelo Mercy College, the Garvan Institute of Medical Research, the Chris OBrien Lifehouse, the Macquarie University Council, and the NSW Private Hospitals Association.
    Mr Andrew Vidler Chief Executive OfficerManaging Director Jan 2024
    Mr Vidler has experience in healthcare and working with health industry professionals in the pharmacy and healthcare service industries. He was most recently Executive General Manager Retail at Wesfarmers Health which included responsibility for the Priceline and Priceline Pharmacy business. Mr Vidler was formerly an Executive General Manager at EBOS Group Limited where, for over 20 years he held leadership roles at Symbion, Mayne Group and FH Faulding.
    Ms Belinda Ann Cleminson Company Secretary Aug 2021
    -
    Belinda Ann Cleminson Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 41,683,931 26.12%
    JP Morgan Nominees Australia Pty Limited 19,929,337 12.49%
    Alison J Hughes 15,797,850 9.90%
    Dr Alexander J Abrahams 13,296,547 8.33%
    National Nominees Limited 10,292,867 6.45%
    UBS Nominees Pty Limited 8,293,207 5.20%
    Citicorp Nominees Pty Limited 6,412,247 4.02%
    Just Paddling Pty Limited 3,454,646 2.16%
    Susan L Abrahams 3,134,314 1.96%
    Robert G Cameron & Paula S Cameron 2,108,480 1.32%
    Channings Holdings Pty Limited 2,090,150 1.31%
    Karen Wright 2,022,000 1.27%
    Sudemo Pty Limited 1,744,863 1.09%
    Lodka Pty Limited 1,322,194 0.83%
    Trevor Collins & Dianne E Collins 1,128,480 0.71%
    Sterling Surgical Pty Limited 900,000 0.56%
    Dianne A Wheeldon 789,132 0.49%
    Warbont Nominees Pty Limited 781,079 0.49%
    Dr David Roessler 766,200 0.48%
    Levigrad Pty Ltd 746,936 0.47%

    Profile

    since

    Note